| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/01/1996 | EP0708592A1 Mts gene, mutations therein, and methods for diagnosing cancer using mts gene sequence |
| 05/01/1996 | EP0542845B1 Plasmodium falciparum antigen for eliciting protective antibodies for use in vaccines |
| 05/01/1996 | EP0491031B1 Cdr grafted anti-cea antibodies and their production |
| 05/01/1996 | EP0441917B1 Pokeweed antiviral protein - monoclonal antibody conjugates |
| 05/01/1996 | CN1121733A Integrative DNA segment comprising gene encoding insecticidal protein |
| 05/01/1996 | CN1121721A Oligonucleotido alky phosphate and alky substituted phosphate |
| 05/01/1996 | CN1031714C Process for preparing urinary follicle stimulating hormone |
| 05/01/1996 | CA2161480A1 Monoclonal antibody to human glicentin, hybridoma for producing said antibody and assay method for human glicentin using said antibody |
| 04/30/1996 | US5512669 Gene encoding bacterial acetoacetyl-COA reductase |
| 04/30/1996 | US5512661 Provides for nucleic acids encoding chimeric neurotrophic factors; for targeting active compounds to cells responsive to neurotropic factor |
| 04/30/1996 | US5512658 Pseudomonas exotoxins (PE) and conjugates thereof having lower animal toxicity with high cytocidal activity through substitution of positively charged amino acids |
| 04/30/1996 | US5512550 Method for inhibiting angiogenesis with modified platelet factor-4 and cleaved platelet factor-4 |
| 04/30/1996 | US5512549 Antidiabetic agents |
| 04/30/1996 | US5512484 Carrot 16 KD protein, gene coding for said protein and plasmid containing said gene |
| 04/30/1996 | US5512483 Expression vectors responsive to steroid hormones |
| 04/30/1996 | US5512482 Plant thioesterases |
| 04/30/1996 | US5512478 Purified dna molecules encoding protein enzymes; bioremediation |
| 04/30/1996 | US5512473 Max-interacting proteins and related molecules and methods |
| 04/30/1996 | US5512472 Genetic engineering |
| 04/30/1996 | US5512468 Process of producing highly transformable bacterial cells and cells produced thereby |
| 04/30/1996 | US5512467 Acyl-peptide hydrolase and methods of production and use |
| 04/30/1996 | US5512466 Expression of a 1-aminocyclopropane-1-carboxylic acid metabolizing enzyme to inhibit production of ethylene |
| 04/30/1996 | US5512463 Enzymatic inverse polymerase chain reaction library mutagenesis |
| 04/30/1996 | US5512462 For amplification of nucleic acid sequences longer than ten kilobases |
| 04/30/1996 | US5512460 Glia activating factor and its production |
| 04/30/1996 | US5512459 Transpeptization by contacting peptide and addition unit with thrombin to cleave leaving unit from core at enzyme cleavage site |
| 04/30/1996 | US5512457 Cytokine designated elk ligand |
| 04/30/1996 | US5512456 Method for the improved production and recovery of poly-β-hydroxybutyrate from transformed Escherichia coli |
| 04/30/1996 | US5512455 Atrial natriuretic peptide receptor protein |
| 04/30/1996 | US5512452 Detecting gene expression in microorganism during infection of host |
| 04/30/1996 | US5512445 Amplification of oligonucleotides |
| 04/30/1996 | US5512443 Second generation monoclonal antibodies having binding specificity to TAG-72 and human carcinomas and methods for employing the same |
| 04/30/1996 | US5512440 Heating with forced hot air in the absence of lysogenic agents |
| 04/30/1996 | US5512439 Oligonucleotide-linked magnetic particles and uses thereof |
| 04/30/1996 | US5512438 Inhibiting RNA expression by forming a pseudo-half-knot RNA at the target's |
| 04/30/1996 | US5512436 Polystyrenesulfonic acid |
| 04/30/1996 | US5512434 Expression cloning of a human phosphatase |
| 04/30/1996 | US5512431 Methods of screening for nucleoside analogs that are incorporated by HIV reverse transcriptase and cause incorrect base pairing |
| 04/30/1996 | US5512421 Generation, concentration and efficient transfer of VSV-G pseudotyped retroviral vectors |
| 04/30/1996 | US5512283 Methods for the selective suppression of an immune response to dust mite der Pi |
| 04/29/1996 | CA2154543A1 Human 26s proteasome subunit components |
| 04/25/1996 | WO1996012185A1 Method for screening compositions |
| 04/25/1996 | WO1996012042A2 Dna polymerases having modified nucleotide binding site for dna sequencing |
| 04/25/1996 | WO1996012040A2 Compositions and methods for the detection of chlamydia trachomatis |
| 04/25/1996 | WO1996012039A1 Massively parallel sequencing of sorted polynucleotides |
| 04/25/1996 | WO1996012033A1 Polycystic kidney disease gene |
| 04/25/1996 | WO1996012030A1 Defective adenoviruses including a therapeutic gene and an immunoprotective gene |
| 04/25/1996 | WO1996012029A1 Aldehyde dehydrogenase selectable markers for plant transformation |
| 04/25/1996 | WO1996012028A1 Production of peptides in plants as viral coat protein fusions |
| 04/25/1996 | WO1996012027A1 Method of producing a chimeric protein |
| 04/25/1996 | WO1996012025A1 TRANSGENIC NONHUMAN ANIMAL HAVING FUNCTIONALLY DISRUPTED INTERLEUKIN-1β CONVERTING ENZYME GENE |
| 04/25/1996 | WO1996012024A1 Cloning, expression and characterisation of a novel form of phosphatidylinositol-3-kinase |
| 04/25/1996 | WO1996012023A1 A recombinant protein designated dev-1, useful in the detection of hiv, dna sequence encoding the protein, and immunoassays using the protein |
| 04/25/1996 | WO1996012022A1 Intracellular isoform of the interleukin-1 receptor antagonist |
| 04/25/1996 | WO1996012021A2 Nematode-extracted serine protease inhibitors and anticoagulant proteins |
| 04/25/1996 | WO1996012020A2 Hemoglobin receptors from neisseriae |
| 04/25/1996 | WO1996012019A2 Her4 human receptor tyrosine kinase or the epidermal growth factor receptor family |
| 04/25/1996 | WO1996012018A2 Novel immunophilins and corresponding nucleic acids |
| 04/25/1996 | WO1996012017A1 Gene participating in apoptosis |
| 04/25/1996 | WO1996012016A1 Neuronal apoptosis inhibitor protein, gene sequence and mutations causative of spinal muscular atrophy |
| 04/25/1996 | WO1996012015A1 Self stabilizing rna/dna loop |
| 04/25/1996 | WO1996012014A1 Molecular tagging system |
| 04/25/1996 | WO1996012013A1 A NOVEL ENZYME WITH β-1,3-GLUCANASE ACTIVITY |
| 04/25/1996 | WO1996012012A1 Lipase, microorganism producing same, method for preparing said lipase and uses thereof |
| 04/25/1996 | WO1996012011A1 Reporter cell line |
| 04/25/1996 | WO1996012010A1 Preparation of rep-negative aav mutants and cells which can be used therefor |
| 04/25/1996 | WO1996012008A1 Synthesis of methylase-resistant genes |
| 04/25/1996 | WO1996012007A1 Stable recombinant hcmv protease |
| 04/25/1996 | WO1996012006A2 Flow through electroporation apparatus and method |
| 04/25/1996 | WO1996011952A1 Method for purifying keratinocyte growth factors |
| 04/25/1996 | WO1996011951A2 Keratinocyte growth factor analogs |
| 04/25/1996 | WO1996011950A1 Method of treating diabetes mellitus using kgf |
| 04/25/1996 | WO1996011949A2 Analogs of keratinocyte growth factor |
| 04/25/1996 | WO1996011947A1 Materials for the production of nanometer structures and use thereof |
| 04/25/1996 | WO1996011946A1 Human endothelin-bombesin receptor |
| 04/25/1996 | WO1996011938A1 Oligonucleotide and carcinostatic agent containing the same as active ingredient |
| 04/25/1996 | WO1996011937A1 Porphyrin labeling of polynucleotides |
| 04/25/1996 | WO1996011712A2 Cell-specific gene delivery vehicles |
| 04/25/1996 | WO1996011708A1 Membrane expression of heterologous genes |
| 04/25/1996 | WO1996011706A1 Use of flea proteases and protease inhibitors to protect animals from flea infestation |
| 04/25/1996 | WO1996011696A1 Screening assay for anti-hiv drugs |
| 04/25/1996 | WO1996011664A2 Nsk2 a muscle receptor tyrosine kinase |
| 04/25/1996 | WO1996011586A1 Preparation of frozen fermented foods using antifreeze polypeptide-expressing microorganisms |
| 04/25/1996 | WO1996011566A1 Gene controlling floral development and apical dominance in plants |
| 04/25/1996 | WO1996004557A3 Target specific screens and their use for discovering small organic molecular pharmacophores |
| 04/25/1996 | WO1996003513A3 Isoamylase gene from flaviobacterium sp., compositions containing it and methods using it |
| 04/25/1996 | WO1996003511A3 Method for producing fatty acids or derivatives thereof from oil plants |
| 04/25/1996 | WO1995035377A3 Materials and methods for detection of oxalate |
| 04/25/1996 | WO1995031541A3 Methods and compositions for treatment of restenosis and cancer using ribozymes |
| 04/25/1996 | DE4438821A1 DNA encoding plant citrate synthase |
| 04/25/1996 | CA2203116A1 Hemoglobin receptors from neisseriae |
| 04/25/1996 | CA2203010A1 Gene controlling floral development and apical dominance in plants |
| 04/25/1996 | CA2202761A1 Method of producing a chimeric protein |
| 04/25/1996 | CA2202664A1 Preparation of rep-negative aav mutants and cells which can be used therefor |
| 04/25/1996 | CA2202628A1 Apoptosis-associated gene |
| 04/25/1996 | CA2202622A1 Use of protease inhibitors and protease vaccines to protect animals from flea infestation, and flea protease proteins, nucleic acid molecules and uses thereof |
| 04/25/1996 | CA2202553A1 Lipase, microorganism producing same, method for preparing said lipase and uses thereof |
| 04/25/1996 | CA2202533A1 Her4 human receptor tyrosine kinase |
| 04/25/1996 | CA2202480A1 Porphyrin labeling of polynucleotides |
| 04/25/1996 | CA2202478A1 Cell-specific gene delivery vehicles |